Size, shape, and flexibility influence nanoparticle transport across brain endothelium under flow

Abstract

Nanoparticle-based therapeutic formulations are being increasingly explored for the treatment of various ailments. Despite numerous advances, the success of nanoparticle-based technologies in treating brain diseases has been limited. Translational hurdles of nanoparticle therapies are attributed primarily to their limited ability to cross the blood-brain barrier (BBB), which is one of the body's most exclusive barriers. Several efforts have been focused on developing affinity-based agents and using them to increase nanoparticle accumulation at the brain endothelium. Very little is known about the role of fundamental physical parameters of nanoparticles such as size, shape, and flexibility in determining their interactions with and penetration across the BBB. Using a three-dimensional human BBB microfluidic model (μHuB), we investigate the impact of these physical parameters on nanoparticle penetration across the BBB. To gain insights into the dependence of transport on nanoparticle properties, two separate parameters were measured: the number of nanoparticles that fully cross the BBB and the number that remain associated with the endothelium. Association of nanoparticles with the brain endothelium was substantially impacted by their physical characteristics. Hard particles associate more with the endothelium compared to soft particles, as do small particles compared to large particles, and spherical particles compared to rod-shaped particles. Transport across the BBB also exhibited a dependence on nanoparticle properties. A nonmonotonic dependence on size was observed, where 200 nm particles exhibited higher BBB transport compared to 100 and 500 nm spheres. Rod-shaped particles exhibited higher BBB transport when normalized by endothelial association and soft particles exhibited comparable transport to hard particles when normalized by endothelial association. Tuning nanoparticles' physical parameters could potentially enhance their ability to cross the BBB for therapeutic applications. K E Y W O R D S

Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges

“…Reproduced with permission. [ 287 ] Copyright 2019, John Wiley & Sons.…”

“…For example, commercially available human microfluidic BBB model (μHUB) was used to investigate the influence of nanoparticle size, shape, and their plastic elasticity on the ability for particles to cross the BBB. [ 287a ] The endothelial cells were seeded in such a way that they form a continuous, hollow lumen of the monolayer throughout the rectangular microchannel. Rod‐shaped stiff carboxylated polystyrene and soft PEG‐diacrylate nanoparticles were synthesized and tested in the membrane‐less parallel PDMS microfluidic design of μHUB model.…”

Nanotherapeutic modulation of excitotoxicity and oxidative stress in acute brain injury

“…72,83 Nanoparticle size, shape, flexibility, and surface charge can be tailored to overcome steric clearance and non-specific binding to alter pharmacokinetics and improve brain accumulation. 84 –86 With a dense poly(ethylene glycol) (PEG) coating, nanoparticles exhibit increased systemic circulation time by reducing interactions that lead to clearance and opsonization. 75 Densely-PEG coated nanoparticles up to 114 nm are also capable of diffusive and convective transport through the brain parenchyma.…”

Zolmitriptan Intranasal Spanlastics for Enhanced Migraine Treatment; Formulation Parameters Optimized via Quality by Design Approach

“…Since 1995, the use of nanoparticles for systemic delivery of therapeutics has increased. Size, shape and flexibility are essential physical parameters that influence nanoparticles' penetration and transport across the BBB [18]. Spanlastics are surfactant-based nanovesicular systems that are modified from niosomes by the addition of edge activators [19].…”